Q2 EPS Estimates for Core Scientific Raised by HC Wainwright

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Analysts at HC Wainwright raised their Q2 2025 earnings estimates for Core Scientific in a note issued to investors on Thursday, May 8th. HC Wainwright analyst K. Dede now forecasts that the company will earn ($0.09) per share for the quarter, up from their prior forecast of ($0.10). HC Wainwright has a "Buy" rating and a $17.00 price target on the stock. The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share. HC Wainwright also issued estimates for Core Scientific's Q3 2025 earnings at $0.02 EPS, Q4 2025 earnings at $0.02 EPS and FY2025 earnings at $0.25 EPS.

Core Scientific (NASDAQ:CORZ - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.10) earnings per share for the quarter, topping analysts' consensus estimates of ($0.12) by $0.02. The business had revenue of $79.53 million during the quarter, compared to analysts' expectations of $92.04 million. During the same period last year, the company earned $0.78 earnings per share. The firm's revenue was down 55.6% compared to the same quarter last year.

Other equities analysts have also issued reports about the stock. Keefe, Bruyette & Woods assumed coverage on shares of Core Scientific in a research report on Monday, January 27th. They issued an "outperform" rating and a $22.00 price objective for the company. Cantor Fitzgerald decreased their price objective on shares of Core Scientific from $24.00 to $21.00 and set an "overweight" rating for the company in a research note on Thursday, February 27th. Craig Hallum started coverage on shares of Core Scientific in a research note on Tuesday, January 21st. They issued a "buy" rating and a $24.00 price objective on the stock. Oppenheimer began coverage on Core Scientific in a research report on Wednesday. They set an "outperform" rating and a $15.00 price target on the stock. Finally, Compass Point decreased their price objective on Core Scientific from $26.00 to $20.00 and set a "buy" rating for the company in a report on Tuesday, February 25th. Sixteen analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of "Buy" and a consensus target price of $18.81.

Core Scientific Price Performance

Shares of CORZ stock traded up $0.08 during mid-day trading on Monday, hitting $10.32. 13,713,477 shares of the stock traded hands, compared to its average volume of 13,037,133. The stock has a market cap of $3.07 billion, a P/E ratio of -1.91 and a beta of 6.66. The stock's fifty day moving average is $7.98 and its two-hundred day moving average is $12.03. Core Scientific has a 52-week low of $3.46 and a 52-week high of $18.63.

Institutional Trading of Core Scientific

A number of institutional investors have recently added to or reduced their stakes in the business. Wellington Shields & Co. LLC purchased a new position in Core Scientific in the 4th quarter worth approximately $26,000. First Horizon Advisors Inc. purchased a new position in Core Scientific in the 4th quarter worth approximately $34,000. Newbridge Financial Services Group Inc. purchased a new stake in Core Scientific during the 4th quarter worth approximately $42,000. Vestcor Inc purchased a new stake in Core Scientific during the 4th quarter worth approximately $66,000. Finally, Emerald Mutual Fund Advisers Trust bought a new stake in shares of Core Scientific in the 1st quarter valued at approximately $38,000.

Insider Buying and Selling

In related news, Director Todd A. Becker sold 134,250 shares of the stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the sale, the director now owns 195,687 shares of the company's stock, valued at $2,103,635.25. This trade represents a 40.69% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jordan Levy purchased 62,500 shares of the firm's stock in a transaction on Thursday, March 6th. The stock was acquired at an average cost of $8.01 per share, for a total transaction of $500,625.00. Following the completion of the purchase, the director now owns 306,887 shares in the company, valued at $2,458,164.87. The trade was a 25.57% increase in their position. The disclosure for this purchase can be found here. 1.40% of the stock is currently owned by corporate insiders.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.